NCT03766178 2021-07-07
Study of Anti-PD-1 Antibody SHR-1210 Plus Nimotuzumab in the Treatment of Advanced Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University
Phase 2 Unknown
Clinical Trials
4 trialsNCT01993784 2013-11-25
Study of Nimotuzumab to Treat Esophageal Squamous Cell Carcinoma.
Peking University
Phase 1/2 Unknown
NCT01402180 2011-07-26
Nimotuzumab
Fudan University
Phase 2/3 Unknown
NCT01336049 2011-04-15
Nimotuzumab Plus Paclitaxel and Cisplatin as 1st Line Treatment for Esophageal Squamous Cell Cancer
Peking University
Phase 2 Unknown